Login / Signup

A randomized trial of serological and cellular responses to hepatitis B vaccination in chronic kidney disease.

Elizabeth N da SilvaAlan BakerJalila AlshekailiKrishna KarpeMatthew C Cook
Published in: PloS one (2018)
CKD confers a specific T cell defect that contributes to the impaired seroconversion to HBV.
Keyphrases
  • hepatitis b virus
  • chronic kidney disease
  • liver failure